Aer Therapeutics, Inc

Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs. We are focused on treating respiratory diseases with significant unmet need, such as COPD, cystic fibrosis and asthma. Our technology was developed and spun out of Dr. John Fahys airway biology lab at University of California San Francisco (UCSF) in collaboration with Dr. Stefan Oscarsons glycochemistry lab at University College Dublin and Dr. Anne Marie Healys pharmaceutics lab at Trinity College Dublin. The efforts of this research consortium led to over $18M in NIH grant funding, resulting...

Aer therapeutics, inc operates in the Pharmaceutical manufacturing industry.

Aer therapeutics, inc's revenue is 1m - 10m

Aer therapeutics, inc has 11 - 50 employees.